CPIG
CNTB icon

Chicago Partners Investment Group’s Connect Biopharma Holdings CNTB Stock Holding History

Chicago Partners Investment Group’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,651
Closed -$17K – 593
2022
Q2 		$17K Buy
20,651
+1,063
+5% +$1.56K ﹤0.01% 588
2022
Q1 		$17K Sell
19,588
-2,304
-11% -$9.72K ﹤0.01% 559
2021
Q4 		$97K Buy
+21,892
New +$243K 0.01% 550

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Chicago Partners Investment Group's CNTB Position: Q3 2022 in Review

Chicago Partners Investment Group sold out of Connect Biopharma Holdings (CNTB) in Q3 2022, closing a stake of 20,651 shares — an estimated $17K sold.

Chicago Partners Investment Group first reported a position in CNTB in Q4 2021 and held it in 3 quarters. The position peaked at $97K in Q4 2021. 25 funds tracked by Wall St. Rank hold CNTB as of Q3 2022.

  • Chicago Partners Investment Group reported no remaining Connect Biopharma Holdings position as of Q3 2022 after selling out during the quarter.
  • Chicago Partners Investment Group sold 20,651 Connect Biopharma Holdings shares in Q3 2022, an estimated $17K.
  • Chicago Partners Investment Group first reported a position in Connect Biopharma Holdings in Q4 2021 and held it in 3 quarters.
  • Chicago Partners Investment Group's Connect Biopharma Holdings position peaked at $97K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2022.

Based on Chicago Partners Investment Group's 13F filing for Q3 2022, filed 9 Nov 2022.